Clinical Trial Update: The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.

View source ↗

Summary

The clinical trial evaluating sympathetic overactivity in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Snippet

Sponsor: AstraZeneca | Conditions: Essential Hypertension | Status: COMPLETED